NBD AI Bulletin - Tonghua Dongbao Pharmaceutical Co Ltd ("the Company", SH 600867, closing price: 13.66 yuan) announced on November 26 that the Company has received a notice concerning the release of pledged shares and re-pledge of shares from controlling shareholder Dongbao Industrial Group Co Ltd. The controlling shareholder on November 25 released 36 million pledged shares and then re-pledged them. Accumulatively, Dongbao Industrial Group Co Ltd has pledged around 539 million shares, including the new pledge, representing 91.08% of its holdings in the Company. 

The semi-annual report shows that Tonghua Dongbao Pharmaceutical Co Ltd mainly engages in business in the pharmaceutical industry, real estate industry, building materials industry, accounting for 96.73%, 1.54%, 0.25% of its revenue, respectively.

Tonghua Dongbao Pharmaceutical Co Ltd's general manager and chairman is Leng Chunsheng, male, 46 years old, Ph.D, senior engineer.

Tips on "Stock Trends":

1. The number of shares held by northbound investors decreased by 7.4595 million in the past 30 days, representing 0.36% of the Company's circulating shares.

2. There was no institutional research on the Company in the past 30 days.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.